Welcome to our dedicated page for Kopin SEC filings (Ticker: KOPN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Kopin Corporation filings document the regulatory record for a public developer of microdisplays and application-specific optical systems. The company’s 8-K reports cover operating results, material agreements, strategic development arrangements, executive compensation awards, and other corporate events tied to its defense, enterprise, industrial, consumer and medical display markets.
Proxy filings describe stockholder meeting matters, board governance, executive compensation, and equity-incentive plan disclosures. Registration statements address securities offerings and capital-structure matters, while periodic-report notices and earnings-related filings provide formal records of reporting status, financial results, revenue categories, research and development activity, funded programs, and risk disclosures associated with Kopin’s display technologies and optical assemblies.
Kopin Corporation CEO Michael Andrew Murray reported an open-market sale of 63,200 shares of Common Stock at a weighted average price of $3.01 per share. The transactions were executed in multiple trades between $3.00 and $3.02 under a pre-arranged Rule 10b5-1 trading plan. Following this sale, he continues to hold 2,867,922 shares of Kopin common stock directly.
KOPIN CORP CEO Michael Andrew Murray sold common stock in a pre-planned transaction. On April 13, 2026, he executed an open-market sale of 187,920 shares at a weighted average price of $2.80 per share under a Rule 10b5-1 trading plan.
After this sale, he directly holds 2,931,122 KOPIN CORP shares, indicating he retains a substantial ownership position in the company.
The filing notifies a proposed sale of 160,000 shares of Common Stock tied to Restricted Stock Units. The cover lists an aggregate value of $435,200.00 and a share count of 183,363,415 with an as of date of 04/15/2026. The excerpt also shows recent 10b5-1 sales: 187,920 shares on 04/13/2026 for $526,765.64, 5,413 shares on 03/26/2026 for $12,179.25, and 33,334 shares on 03/25/2026 for $77,238.21.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice to sell 160,000 shares of Common Stock represented by Restricted Stock Units scheduled 12/10/2024, with the filing dated 04/13/2026 and the shares listed as NASDAQ. The filing also reports recent 10b5-1 sales by Michael Murray of 5,413 and 33,334 shares on 03/26/2026 and 03/25/2026, respectively.
Kopin Corporation is a Delaware-based microdisplay and optical systems company focused on defense, industrial, medical and emerging AR/VR markets. It supplies AMLCD, LCOS, OLED and developing MicroLED displays, plus integrated Application Specific Optical Solutions and headsets for demanding near-eye applications.
For fiscal 2025, total revenues were $39.3 million, down from $50.3 million in 2024, with defense product sales remaining the majority but declining year over year. The company continues to invest heavily in R&D, including its NeuralDisplay™ architecture and MicroLED programs supported by U.S. Department of War IBAS funding.
Kopin ended 2025 with $61.6 million in cash, cash equivalents, restricted cash and marketable securities after raising capital through a public offering and a $41 million private placement. The company has an accumulated deficit of $399.5 million, continues to use cash in operations, and warns it may need additional financing if profitability is not achieved.
Management reports material weaknesses in internal control over financial reporting that remained unresolved as of December 27, 2025, and expects remediation work to continue into 2026. Key risks include customer concentration in defense, reliance on specialized foundries, supply chain and geopolitical exposures, fixed-price government contracts, cybersecurity threats, and extensive regulatory requirements.
KOPIN CORP CEO Michael Andrew Murray reported an open-market sale of 5,413 shares of Common Stock at $2.25 per share on March 26, 2026. The transaction was effected under a Rule 10b5-1 trading plan adopted on November 24, 2025, and he now directly holds 3,119,042 shares.
Kopin Corporation will not file its Annual Report on Form 10-K for the year ended December 27, 2025 within the prescribed time period. The company cites fourth-quarter financing transactions that raise complex U.S. GAAP recognition, measurement, and presentation issues and is evaluating related valuations. Kopin expects to file the Annual Report within the fifteen calendar day extension provided by Rule 12b-25. The company also states a fourth-quarter deconsolidation that is expected to affect reported results, including recognition of gains or losses and changes in presentation.
KOPIN CORP CEO Michael Andrew Murray reported an open-market sale of 33,334 shares of common stock at a weighted average price of $2.317 per share. The sales were executed under a Rule 10b5-1 trading plan adopted on November 24, 2025. Following the transaction, he directly owns 3,124,455 shares of Kopin common stock, indicating this was a relatively small portion of his overall holdings.
Kopin Corp: The Vanguard Group filed an amendment to its Schedule 13G reporting beneficial ownership of 0 shares of Common Stock, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026, under which certain Vanguard subsidiaries and business divisions will report ownership separately.
The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026, and cites SEC Release No. 34-39538 regarding disaggregation of previously aggregated holdings.
Kopin Corporation reported a sharp revenue decline for Q4 2025 but highlighted a much stronger balance sheet and expanding defense partnerships. Total revenues were $8.4 million, down from $14.6 million in Q4 2024, mainly due to a U.S. government shutdown that delayed defense-related orders and shipments. Product revenues fell to $5.6 million from $12.6 million, while non-product revenues, including funded R&D and grants, rose to $2.5 million from $1.7 million, helped by color MicroLED development work.
Despite weaker sales, Kopin completed a $56 million private placement from strategic and institutional investors and ended December 27, 2025 with $37.8 million in cash and cash equivalents, plus $23.0 million of bonded cash recorded as a long-term asset. Management emphasized growing strategic programs, including its partnership with Theon International and multiple U.S. defense programs supported by congressional budgets through 2030, and expressed confidence that order flow is normalizing into 2026.